Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?
Parrillo
J E
JE
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D003951:Diagnostic Errors; D023381:Endpoint Determination; D006333:Heart Failure / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009205:Myocarditis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012075:Remission, Spontaneous; D012107:Research Design / Q000592:standards; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents